Eikon Therapeutics, Inc.

EIKN

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091798
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Klobuchar Michael A (COO)
SEC Filing link

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions ⓘ

Transaction 1

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+87,157.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

87,157.0

Filing's footnotes

1. 1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.